GlassScriptPhysician profile
Anthony L Florian
NPI 1962500819
$767.35
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $268 · 2021: $108.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $179.46 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.13 | 2019-2020 | |
| Allergan, INC. | $62.36 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $54.97 | 2020 | |
| Pfizer INC. | $54.39 | 2019-2021 | |
| Ascend Therapeutics US, LLC | $36.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $32.92 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $27.33 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.22 | 2019 | |
| Glaxosmithkline, LLC. | $26.75 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $21.80 | 2019 | |
| Astellas Pharma US INC | $21.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.40 | 2019 | |
| Abbott Laboratories | $16.29 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.91 | 2019 | |
| Lilly USA, LLC | $15.70 | 2019 | |
| Sanofi Pasteur INC. | $15.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.76 | 2019 | |
| Hikma Pharmaceuticals USA | $14.44 | 2019 | |
| Eisai INC. | $13.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Florian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.